| |
KOMISJA NADZORU FINANSOWEGO |
|
| |
|
|
Raport bieżący nr |
7 |
/ |
2021 |
|
|
|
| |
Data sporządzenia: |
2021-02-24 |
|
|
|
|
|
|
|
|
|
| |
Skrócona nazwa emitenta |
|
|
|
|
|
|
|
|
|
| |
MILESTONE MEDICAL |
|
| |
Temat |
|
|
|
|
|
|
|
|
|
|
| |
Receiving a Notice of Allowance for U.S Patent Related to Breakthrough CompuPulse
System
|
|
| |
Podstawa prawna |
|
|
|
|
|
|
|
|
| |
Art. 17 ust. 1 MAR - informacje poufne.
|
|
| |
Treść raportu: |
|
|
|
|
|
|
|
|
|
| |
The Board of Directors of Milestone Medical Inc. _WAR: MMD, “the Company", “the Issuer"_,
today announced that Milestone Scientific, Inc. _NYSE:MLSS_, the licensor and the
majority shareholder of the Issuer has received a Notice of Allowance from the United
States Patent and Trademark Office _USPTO_ related to its new CompuPulse System, which
integrates the Company’s CompuWave™ technology with a manual syringe.
The Board of Directors of the Company is pleased that its licensor received this Notice
of Allowance related to new CompuPulse System, which combines the benefits of CompuWave
technology with a manual syringe. Importantly, the new CompuPulse System allows one
to identify a pulsatile pressure waveform in a variety of applications, thereby improving
the reliability and safety of a drug delivery procedure. Importantly, not all procedures
require the sophistication of our CompuFlo system, which precisely controls the administration
and flow rate of medication as it is being administered. This new technology provides
an efficient and low cost alternative for procedures where a manual syringe may suffice,
while still providing the ability to verify needle and subsequent catheter placement.
The Board of Directors of the Company believes that this Notice of Allowance significantly
expands the intellectual property of Milestone Scientific surrounding the injection
and drug delivery systems and, in turn, further solidifies its leadership position
in the computerized injection market. The Board of Directors of the Issuer believes
the combination of the CompuWave technology with the lower cost of a manual syringe
opens up a number of exciting new markets and applications for the technology, while
still ensuring precise confirmation of needle placement and verification that a catheter
has not been displaced during or after a procedure.
The Notice of Allowance relates to a method and an apparatus that detects a pulsatile
pressure waveform to more easily perform the identification of anatomical target regions.
The pulsatile waveform is representative of the detection of pressures that are produced
by the cardio-vascular system either directly or indirectly. This same system can
be used to aid in the determination of the patency of a catheter and to assist in
determining if a catheter has been displaced during a procedure.
|
|
|
RB_ASO: Receiving a Notice of Allowance for U.S Patent Related to Breakthrough CompuPulse
System
